My clinical specialty is pediatric emergency medicine. I was influenced to become a physician by my experiences with my pediatrician while growing up. I also had wonderful mentors in medical school and during my residency and fellowship.
My area of research interest is anaphylaxis, which is a severe, potentially life-threatening acute allergic reaction. I care for a lot of children with anaphylaxis in the emergency department (ED), and I’m driven to learn how to improve the recognition and management of anaphylaxis both in the ED and community. My work aims to determine how long children should be observed in the ED or inpatient setting to monitor for biphasic reactions. Additionally, my research team seeks to identify diagnostic and predictive anaphylaxis biomarkers and to evaluate barriers to the delivery of anaphylaxis best practices in the ED and outpatient setting. I am grateful for the patients and families who participate in my research in the hope that we can improve the care and outcomes of children with and at risk of anaphylaxis.
I am a board certified pediatrician (2015) and pediatric emergency medicine physician (2019). I’m honored to have received the Center for Clinical and Translational Science and Training (CCTST) KL2 award (2021) and the research prize through the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) through the section of emergency medicine of the American Academy of Pediatrics (2019).
BS: Biology, University of Missouri-Columbia, Columbia, MO, 2008.
MD: University of Missouri-Columbia, Columbia, MO, 2012.
Residency: Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, 2015.
Fellowship: Pediatric Emergency Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, 2018.
Anaphylaxis; allergic reactions; situational awareness
Anaphylaxis knowledge gaps and future research priorities: A consensus report. Journal of Allergy and Clinical Immunology. 2022; 149:999-1009.
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Journal of Allergy and Clinical Immunology: In Practice. 2021; 9:3546-3567.
Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. Journal of Allergy and Clinical Immunology. 2021; 148:173-181.
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. Journal of Allergy and Clinical Immunology. 2020; 146:1089-1096.
Are Children with a History of Asthma More Likely to Have Severe Anaphylactic Reactions? A Retrospective Cohort Study. The Journal of Pediatrics. 2020; 220:159-164.e2.
Timing and predictors of repeat epinephrine administration among children hospitalized for anaphylaxis. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:1400-1402.e2.
Trends in emergency care for anaphylaxis. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:767-768.e2.
Identification of children with anaphylaxis at low risk of receiving acute inpatient therapies. PloS one. 2019; 14:e0211949.
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. Journal of Allergy and Clinical Immunology. 2023; 152:309-325.
Overview of Allergy and Anaphylaxis. Immunology and Allergy Clinics of North America. 2023; 43:435-451.